http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2584863-T3
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1543b2b19ec0e331a0dcd89888cbef5f |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 |
filingDate | 2004-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2016-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_384ff014bd17f8e5b67bfd17dedd2563 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71cff9346fcdc216bee250d497ac7101 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57c66396a083a387b475975f6c2f953d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac087dc6ddc88b76734adafb8a473121 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4152d4fde08d177648c65b98395998dd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea2f48ae1da886c2a1ca97f23dbbb003 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58cb2d9e28139dec7180c8a92d8a23ee http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb71a99959776a5072bbbacedeb715d6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6f5d88d4c1c9de1cad20cc4190d6dc5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b9239c89f11767ebd07dc4b7ad3149c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0f466c46621e211690005ce986bccb5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf5623f810355950b941b161a3ae6a88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c956723a08ce67751b6015f70d06c6d |
publicationDate | 2016-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | ES-2584863-T3 |
titleOfInvention | Pyrazolopyridines and analogues thereof |
abstract | A compound of Formula (III, IV, V, VI, VII, or VIII): ** Formula ** wherein: R1 is selected from the group consisting of: -R4, -X-R4, -XY-R4, -XYXY-R4, and -X-R5; R2 is selected from the group consisting of hydrogen, alkyl, arylalkylenyl, alkoxyalkylene, and hydroxyalkylene; m is 0, n is 1, and R is selected from the group consisting of hydroxy and methoxy; or m is 1, n is 0, and R3 is selected from the group consisting of aryl, arylalkylenoxy, and heteroaryl, wherein aryl, arylalkylenoxy, and heteroaryl are unsubstituted or substituted by one or more substituents selected from the group consisting of alkyl and halogen; or m and n are 0; X is selected from the group consisting of alkylene, alkenylene, alkynylene, arylene, heteroarylene, and heterocyclylene where the alkylene, alkenylene, and alkynylene groups can be optionally interrupted or terminated by arylene, heteroarylene, or heterocyclylene, and optionally interrupted by one or more groups -O-; Y is selected from the group consisting of: ** Formula ** R4 is selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, aryl, arylalkylenyl, aryloxyalkylenyl, alkylaryl, heteroaryl, heteroarylalkylenyl, heteroaryloxyalkylenyl, alkylheteroarylenyl, and heterocyclyl where alkyl, alkenyl, alkynyl, aryl, arylalkylenyl, aryloxyalkylenyl, alkylarynyl, heteroaryl, heteroarylalkylenyl, heteroaryloxyalkylene, alkylheteroarylenyl, and heterocyclyl groups may be unsubstituted or substituted by one or more substituents, consisting of alkyl, alkoxy, haloalkyl, haloalkoxy, halogen, nitro, hydroxy, mercapto, cyano, aryl, aryloxy, arylalkylenoxy, heteroaryl, heteroaryloxy, heteroarylalkyleneoxy, heterocyclyl, amino, alkylamino, dialkylamino, (dialkylamino) alkylexy, and in the case of alkyl, alkenyl, alkyl, and heterocyclyl, oxo; R5 is selected from the group consisting of ** Formula ** R6 is selected from the group consisting of> = O and> = S; R7 is C2-7 alkylene; R8 is selected from the group consisting of hydrogen, alkyl, alkoxyalkylene, hydroxyalkylene, arylalkylenyl, and heteroarylalkylenyl; R9 is selected from the group consisting of hydrogen and alkyl; R10 is C3-8 alkylene; A is selected from the group consisting of -O-, -C (O) -, -S (O) 0-2-, and -N (R4) -; A 'is selected from the group consisting of -O-, -S (O) 0-2-, -N (-Q-R4) -, and -CH2-; Q is selected from the group consisting of a bond, -C (R6) -, -C (R6) -C (R6) -, -S (O) 2-, -C (R6) -N (R8) -W -, - S (O) 2-N (R8) -, -C (R6) -O-, -C (R6) -S-, and -C (R6) -N (OR9) -; V is selected from the group consisting of -C (R6) -, -O-C (R6) -, -N (R8) -C (R6) -, and -S (O) 2-; W is selected from the group consisting of a bond, -C (O) -, and -S (O) 2-; a and b are independently integers from 1 to 6 with the proviso that a + b is 7; and where the terms "alkyl", "alkenyl", "alkynyl" and the prefix "alc (qu) -" refer to straight and branched chain groups and also to cyclic groups, containing from 1 to 20 carbon atoms , with alkenyl groups containing from 2 to 20 carbon atoms and alkynyl groups containing from 2 to 20 carbon atoms, where the cyclic groups can be monocyclic or polycyclic; or one of its pharmaceutically acceptable salts. |
priorityDate | 2003-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 755.